Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3551
PUT
Pilgrim's Pride
PPC
$6.64B
| $6.36M | ﹤0.01% |
140,100
+28,600
| +26% | +$1.39M |
|
3552
HUB Group
HUBG
$2.46B
| $6.35M | ﹤0.01% |
142,584
+26,572
| +23% | +$1.24M |
|
|
VNET
3553
VNET Group
VNET
$2.16B
| $6.34M | ﹤0.01% |
1,337,898
+860,967
| +181% | +$3.27M |
|
3554
PUT
Credit Acceptance
CACC
$6.1B
| $6.34M | ﹤0.01% |
13,500
-2,900
| -18% | -$1.34M |
|
3555
Protagonist Therapeutics
PTGX
$10B
| $6.34M | ﹤0.01% |
164,146
+159,116
| +3,163% | +$6.94M |
|
3556
CALL
Citizens Financial Group
CFG
$31.5B
| $6.33M | ﹤0.01% |
144,700
-220,700
| -60% | -$9.76M |
|
3557
PUT
Corteva
CTVA
$51.2B
| $6.32M | ﹤0.01% |
111,000
+68,300
| +160% | +$4.04M |
|
3558
SIGA Technologies
SIGA
$216M
| $6.32M | ﹤0.01% |
1,051,903
-16,668
| -2% | -$111K |
|
3559
PUT
Skywest
SKYW
$4.18B
| $6.32M | ﹤0.01% |
63,100
+19,400
| +44% | +$1.98M |
|
3560
CALL
Sterling Infrastructure
STRL
$17.6B
| $6.32M | ﹤0.01% |
37,500
+11,300
| +43% | +$1.95M |
|
3561
PUT
AvalonBay Communities
AVB
$26.3B
| $6.31M | ﹤0.01% |
28,700
-19,800
| -41% | -$4.47M |
|
3562
CALL
Harrow
HROW
$1.5B
| $6.31M | ﹤0.01% |
188,100
-35,300
| -16% | -$1.56M |
|
3563
Vanguard S&P 500 Growth ETF
VOOG
$27.3B
| $6.31M | ﹤0.01% |
103,416
+70,338
| +213% | +$4.22M |
|
3564
Coursera
COUR
$1.53B
| $6.31M | ﹤0.01% |
742,080
+50,679
| +7% | +$391K |
|
|
SKX
3565
PUT
DELISTED
Skechers
SKX
| $6.31M | ﹤0.01% |
93,800
+17,800
| +23% | +$1.15M |
|
3566
CALL
Cenovus Energy
CVE
$57.2B
| $6.31M | ﹤0.01% |
416,300
+50,100
| +14% | +$806K |
|
3567
National Health Investors
NHI
$3.58B
| $6.3M | ﹤0.01% |
90,955
+47,911
| +111% | +$3.64M |
|
3568
CALL
PTC
PTC
$16.2B
| $6.29M | ﹤0.01% |
34,200
-28,600
| -46% | -$5.42M |
|
3569
CALL
NovoCure
NVCR
$1.97B
| $6.28M | ﹤0.01% |
210,900
+43,600
| +26% | +$923K |
|
|
SEI
3570
Solaris Energy Infrastructure
SEI
$4.17B
| $6.28M | ﹤0.01% |
218,130
-17,575
| -7% | -$350K |
|
|
SLNO
3571
CALL
DELISTED
Soleno Therapeutics
SLNO
| $6.28M | ﹤0.01% |
139,600
+126,700
| +982% | +$6.56M |
|
3572
CALL
BioMarin Pharmaceuticals
BMRN
$13B
| $6.27M | ﹤0.01% |
95,400
-41,400
| -30% | -$2.77M |
|
|
HI
3573
DELISTED
Hillenbrand
HI
| $6.27M | ﹤0.01% |
203,628
+176,937
| +663% | +$5.35M |
|
3574
CALL
ProShares Ether Strategy ETF
EETH
$54.1M
| $6.27M | ﹤0.01% |
95,500
+15,300
| +19% | +$940K |
|
3575
Champion Homes
SKY
$5.13B
| $6.26M | ﹤0.01% |
71,103
-117,687
| -62% | -$11.4M |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.